hrp0098p1-156 | GH and IGFs 2 | ESPE2024
Polak Michel
, Bouhours-Nouet Natacha
, van Dommelen Paula
, Berger Sophie
, Castello-Bridoux Claire
, Untereiner Raphaël
, Koledova Ekaterina
, Tauber Maithé
, Linglart Agnès
Background: The Study and Collection of Observational data for Patients with easypod® Connect (SCOPE) French retrospective study follows children with growth disorders treated with recombinant human growth hormone (r-hGH) therapy via the easypod® connected injection device for up to 5 years.Aim: To show the results from the SCOPE study analysing the adherence to r-hGH therapy in a real-world setting and its effec...